BIO-MYCIN 200- oxytetracycline injection

Nchi: Marekani

Lugha: Kiingereza

Chanzo: NLM (National Library of Medicine)

Viambatanisho vya kazi:

OXYTETRACYCLINE (UNII: X20I9EN955) (OXYTETRACYCLINE ANHYDROUS - UNII:SLF0D9077S)

Inapatikana kutoka:

Boehringer Ingelheim Animal Health USA Inc.

Njia ya uendeshaji:

INTRAMUSCULAR

Dawa ya aina:

OTC

Matibabu dalili:

BIO-MYCIN 200 is intended for use in the treatment of the following diseases in beef cattle, dairy cattle and swine when due to oxytetracycline-susceptible organisms: Cattle: In cattle, BIO-MYCIN 200 is indicated in the treatment of pneumonia and shipping fever complex associated with Pasteurella spp. and Haemophilus spp.; infectious bovine keratoconjunctivitis (pinkeye) caused by Moraxella bovis ; foot-rot and diphtheria caused by Fusobacterium necrophorum ; bacterial enteritis (scours) caused by Escherichia coli ; wooden tongue caused by Actinobacillus lignieresii ; leptospirosis caused by Leptospira pomona ; and wound infections and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline. Swine: In swine, BIO-MYCIN 200 is indicated in the treatment of bacterial enteritis (scours, colibacillosis) caused by Escherichia coli ; pneumonia caused by Pasteurella multocida ; and leptospirosis caused by Leptospira pomona . In sows, BIO-MYCIN 200 is indicated as an

Bidhaa muhtasari:

BIO-MYCIN 200 is available in 100-mL, 250-mL, and 500-mL bottles containing 200 mg oxytetracycline per mL.

Idhini hali ya:

Abbreviated New Animal Drug Application

Tabia za bidhaa

BIO-MYCIN 200- OXYTETRACYCLINE INJECTION
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
----------
BIO-MYCIN® 200
(OXYTETRACYCLINE INJECTION)
ANTIBIOTIC
Approved by FDA under ANADA # 200-008
Each mL contains 200 mg oxytetracycline.
For the treatment of disease in beef cattle, dairy cattle and swine.
For animal use only
READ ENTIRE INSERT CAREFULLY BEFORE USING THIS PRODUCT.
BIO-MYCIN 200 is a sterile, ready-to-use solution of the broad
spectrum antibiotic
oxytetracycline by injection. Oxytetracycline injection administered
to cattle or swine for
the treatment of bacterial pneumonia at a dosage of 9 mg of
oxytetracycline per lb of
body weight has been demonstrated in clinical trials to be as
effective as 2 or 3
repeated, daily treatments of oxytetracycline injectable 50 mg/mL at
3-5 mg/lb of body
weight. Each mL contains 200 mg of oxytetracycline; magnesium oxide
1.7% w/v;
sodium formaldehyde sulfoxylate 0.5% w/v; polyethylene glycol 400 30%
w/v;
monoethanolamine to adjust pH; water for injection USP qs. The
antibiotic activity of
oxytetracycline is not appreciably diminished in the presence of body
fluids, serum or
exudates.
CAUTION:
When administered to cattle, muscle discoloration may necessitate
trimming of the
injection site(s) and surrounding tissues during the dressing
procedure.
WARNING:
Discontinue treatment at least 28 days prior to slaughter of cattle
and swine. Milk taken
from animals during treatment and for 96 hours after the last
treatment must not be
used for food.
Rapid intravenous administration may result in animal collapse.
Oxytetracycline should
be administered intravenously slowly over a period of at least 5
minutes.
PRECAUTIONS:
Exceeding the highest recommended dosage level of drug per pound of
body weight per
day, administering more than the recommended number of treatments
and/or
exceeding 10 mL intramuscularly or subcutaneously per injection site
in adult beef cattle
and dairy cattle, and 5 mL intramuscularly per injection site in adult
swine, may result in
antibiotic residues beyond the w